This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
KBR Secures $450M Contracts for U.S. Government Support
by Zacks Equity Research
KBR clinches deals with the U.S. government, bolstering national security and technological advancement.
KBR Wins Engineering Services Contract From First State Hydrogen
by Zacks Equity Research
KBR wins contract to aid First State Hydrogen in the U.S. hydrogen facility.
BCKIY or ALTR: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
BCKIY vs. ALTR: Which Stock Is the Better Value Option?
AECOM (ACM) to be Lead Consultant & Designer for M80 Ring Road
by Zacks Equity Research
AECOM (ACM) benefits from increasing infrastructural spending trends in and outside of the U.S. markets, along with several strategic initiatives.
KBR's Purifier Process to Help Build NCIC's Fertilizer Complex
by Zacks Equity Research
KBR's focus on high-end and differentiated government business work, strong margin performance, technology and consulting services is encouraging.
Strength Seen in ChampionX (CHX): Can Its 10.4% Jump Turn into More Strength?
by Zacks Equity Research
ChampionX (CHX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Stratasys (SSYS) Forms Advisory Board for Additive Manufacturing
by Zacks Equity Research
Stratasys (SSYS) forms a fresh Customer Advisory Board to foster cooperation and creativity in additive manufacturing.
KBR Wins $61M Task Order to Support Defense Health Agency
by Zacks Equity Research
KBR's focus on high-end and differentiated government business work, strong margin performance, technology and consulting services is encouraging.
BCKIY vs. ALTR: Which Stock Is the Better Value Option?
by Zacks Equity Research
BCKIY vs. ALTR: Which Stock Is the Better Value Option?
Howmet (HWM) to Benefit From Business Strength Amid Risks
by Zacks Equity Research
Howmet (HWM) stands to gain from strength in the commercial aerospace, and oil and gas markets. However, rising costs pose a threat to its profitability.
Quanta (PWR) Stock Rises 32.1% in 6 Months: More Room to Run?
by Zacks Equity Research
More demand for infrastructural solutions, renewable drive, buyouts and solid backlog aids Quanta (PWR). Yet the cyclicality of business ails.
Sterling's (STRL) Arm Receives $100M Data Center Project
by Zacks Equity Research
Sterling (STRL) banks on regular contract wins and solid project execution.
Stratasys (SSYS) Boosts Innovation With Arevo Acquisition
by Zacks Equity Research
Stratasys (SSYS) enhances its position in additive manufacturing by acquiring Arevo's technology portfolio.
Willdan (WLDN) Wins $46M Clark County School District Contract
by Zacks Equity Research
Willdan (WLDN) is set to transform Nevada's learning environment in the next 10 years.
BCKIY vs. ALTR: Which Stock Is the Better Value Option?
by Zacks Equity Research
BCKIY vs. ALTR: Which Stock Is the Better Value Option?
ACM or ALTR: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
ACM vs. ALTR: Which Stock Is the Better Value Option?
Bull of the Day: Fluor (FLR)
by Shaun Pruitt
Flour Corporation's (FLR) stellar price performance over the last few years looks likely to continue into 2024 with its stock starting to check the boxes in many fundamental areas.
Stratasys (SSYS) Enhances Tumor Surgery With 3D-Printed Guides
by Zacks Equity Research
Stratasys (SSYS) contributes to the advancement of craniomaxillofacial tumor surgery at University Hospital Birmingham through the utilization of 3D-printed tailored surgical guides.
ACM vs. ALTR: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
ACM vs. ALTR: Which Stock Is the Better Value Option?
Stratasys (SSYS) & Siemens Team Up to Enhance Medical Imaging
by Zacks Equity Research
Stratasys (SSYS) collaborates with Siemens Healthineers in a groundbreaking research initiative to propel advancements in medical imaging.
Sherwin-Williams (SHW) Q3 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Sherwin-Williams (SHW) delivered earnings and revenue surprises of 15.52% and 1.87%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
Down -16.14% in 4 Weeks, Here's Why You Should You Buy the Dip in Altair Engineering (ALTR)
by Zacks Equity Research
Altair Engineering (ALTR) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Down -18.35% in 4 Weeks, Here's Why You Should You Buy the Dip in Altair Engineering (ALTR)
by Zacks Equity Research
Altair Engineering (ALTR) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
Altair Engineering (ALTR) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
Altair Engineering (ALTR) delivered earnings and revenue surprises of 25% and 1.68%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
AECOM (ACM) Wins 7-Year Deal to Design Cloudburst Strategies
by Zacks Equity Research
AECOM's (ACM) recent deal to support NYCDEP's cloudburst management program.